Q1 2025 Holdings
Filed 2025-05-14 | 94 holdings | $870.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| United Health Group Inc(UNH) | COM | 91324P102 | $40.6M | 77,430 | 4.7% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $34.5M | 41,750 | 4.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $32.4M | 66,750 | 3.7% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $31.8M | 47,217 | 3.7% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $30.3M | 300,000 | 3.5% |
| Glaukos Corp(GKOS) | COM | 377322102 | $26.6M | 270,000 | 3.1% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $26.2M | 233,500 | 3.0% |
| Procept Biorobotics Corp(PRCT) | COM | 74276L105 | $26.1M | 448,000 | 3.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $25.5M | 51,500 | 2.9% |
| Alignment Healthcare Inc(ALHC) | COM | 01625V104 | $24.9M | 1,337,284 | 2.9% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $22.9M | 255,000 | 2.6% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $22.5M | 68,200 | 2.6% |
| Elevance Health Inc(ELV) | COM | 036752103 | $21.3M | 48,950 | 2.4% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $20.1M | 31,750 | 2.3% |
| Cooper COS Inc(COO) | COM | 216648501 | $19.9M | 236,000 | 2.3% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $19.8M | 325,000 | 2.3% |
| Natera Inc(NTRA) | COM | 632307104 | $19.6M | 138,500 | 2.3% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $19.0M | 440,000 | 2.2% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $18.7M | 265,000 | 2.2% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $18.6M | 88,650 | 2.1% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $17.0M | 126,700 | 2.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $16.0M | 61,000 | 1.8% |
| CVS Health Corp(CVS) | COM | 126650100 | $16.0M | 235,862 | 1.8% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $15.4M | 124,300 | 1.8% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $14.2M | 185,500 | 1.6% |
| Oscar Health Inc(OSCR) | CL A | 687793109 | $13.4M | 1,022,743 | 1.5% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $13.0M | 48,197 | 1.5% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $12.8M | 411,000 | 1.5% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $12.8M | 109,600 | 1.5% |
| Humana Inc(HUM) | COM | 444859102 | $12.4M | 46,830 | 1.4% |
| Dexcom Inc(DXCM) | COM | 252131107 | $10.6M | 155,000 | 1.2% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $9.9M | 89,817 | 1.1% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $9.9M | 87,250 | 1.1% |
| The Cigna Group(CI) | COM | 125523100 | $9.3M | 28,200 | 1.1% |
| Cencora Inc(COR) | COM | 03073E105 | $9.0M | 32,375 | 1.0% |
| Danaher Corporation(DHR) | COM | 235851102 | $8.6M | 41,952 | 1.0% |
| Centene Corp del(CNC) | COM | 15135B101 | $7.6M | 126,000 | 0.9% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $7.3M | 565,000 | 0.8% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $7.0M | 177,500 | 0.8% |
| Abbott Labs(ABT) | COM | 002824100 | $6.9M | 52,000 | 0.8% |
| Biogen Inc(BIIB) | COM | 09062X103 | $6.8M | 49,500 | 0.8% |
| Align Technology Inc(ALGN) | COM | 016255101 | $6.6M | 41,500 | 0.8% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $6.3M | 12,640 | 0.7% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $5.8M | 16,778 | 0.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $5.3M | 433,000 | 0.6% |
| Anteris Technologies Global(AVR) | COM | 03675P102 | $4.7M | 1,290,000 | 0.5% |
| Astrana Health Inc(ASTH) | COM NEW | 03763A207 | $4.7M | 150,000 | 0.5% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $4.4M | 70,000 | 0.5% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $4.4M | 19,000 | 0.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $4.2M | 104,250 | 0.5% |